All News

Cambridge Antibody Technology Group Plc, which is traded on both the LSE and Nasdaq markets, said an agreement was struck at the 11th hour over a royalty dispute with Abbott Laboratories Inc.

Oxford Genome licenses a genomic database with a long pedigree to Belgium’s UCB

Philips is seeking to boost adoption of its clock-less integrated circuit technology, offering it at a knockdown price to universities and research institutions.

A Karolinska team is using microarrays for adjuvant therapy – and is looking for partners

Nuala’s Moran’s roundup of news and views in the management of intellectual assets focuses on how to keep alliances happy

Wouldn’t you like to read the minds of the people you do business with? Sorry, fMRI doesn't do that, but it does try to see what goes on in the brain.

A microchip that mimics the function of the human brain could one day result in a mobile phone with the memory capacity of a desktop computer, researchers report.

The official Irish government report on the failed Media Lab Europe project has focused attention another industry-academic research partnerships – one involving Bell Labs and a consortium of eight Irish universities.

A spin-out from the University of Southampton, UK, has a new “scintillation detector” that it says can help stop radiological threats at airports and elsewhere.

Physicists in Bangalore have developed new uses for carbon nanotubes – as flow sensors. Now they are looking for more licensees to develop their work.

New technology to repair the meniscus in the knee is under development at the University of Bristol, UK.

A novel procedure for the preparation of β-lactams, from non-natural substrates.

Undersea automation to deal with imaging, inspection, mapping, profiling, surveillance, classification and exploration.

This device delivers large molecules directly into cells, and even into specific sites within cells, whilst avoiding the cellular damage associated with other drug delivery methods.

A new class of antibiotics, to tackle MRSA and other multi-resistant organisms, is in development by a spin-off from the University of Surrey, UK.